HK1193815A1 - 對澱粉狀蛋白具有親和性的化合物 - Google Patents

對澱粉狀蛋白具有親和性的化合物

Info

Publication number
HK1193815A1
HK1193815A1 HK14107164.9A HK14107164A HK1193815A1 HK 1193815 A1 HK1193815 A1 HK 1193815A1 HK 14107164 A HK14107164 A HK 14107164A HK 1193815 A1 HK1193815 A1 HK 1193815A1
Authority
HK
Hong Kong
Prior art keywords
amyloid
affinity
compound
Prior art date
Application number
HK14107164.9A
Other languages
English (en)
Inventor
奧村侑紀
真矢啓史
正山祥生
大西崇子
Original Assignee
日本醫事物理股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本醫事物理股份有限公司 filed Critical 日本醫事物理股份有限公司
Publication of HK1193815A1 publication Critical patent/HK1193815A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14107164.9A 2011-05-20 2014-07-14 對澱粉狀蛋白具有親和性的化合物 HK1193815A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011114198 2011-05-20
PCT/JP2012/062778 WO2012161116A1 (ja) 2011-05-20 2012-05-18 新規アミロイド親和性化合物

Publications (1)

Publication Number Publication Date
HK1193815A1 true HK1193815A1 (zh) 2014-10-03

Family

ID=47217193

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14107164.9A HK1193815A1 (zh) 2011-05-20 2014-07-14 對澱粉狀蛋白具有親和性的化合物

Country Status (11)

Country Link
US (1) US9149546B2 (zh)
EP (1) EP2716641B1 (zh)
JP (1) JP5272110B2 (zh)
KR (1) KR20140040722A (zh)
CN (1) CN103534253B (zh)
AU (1) AU2012259929B2 (zh)
CA (1) CA2836872A1 (zh)
ES (1) ES2628221T3 (zh)
HK (1) HK1193815A1 (zh)
TW (1) TWI528977B (zh)
WO (1) WO2012161116A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9267232B2 (en) 2005-03-24 2016-02-23 Tarkett Inc. Synthetic turf system having an infill trapping structure
JP5385155B2 (ja) 2007-02-05 2014-01-08 ボストン サイエンティフィック リミテッド 血栓除去装置
US9510854B2 (en) 2008-10-13 2016-12-06 Boston Scientific Scimed, Inc. Thrombectomy catheter with control box having pressure/vacuum valve for synchronous aspiration and fluid irrigation
CA2839199C (en) * 2011-06-24 2018-11-06 Nihon Medi-Physics Co., Ltd. Novel compound with amyloid affinity
JP6041751B2 (ja) * 2013-05-07 2016-12-14 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
JP2014218454A (ja) * 2013-05-07 2014-11-20 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
US9883877B2 (en) 2014-05-19 2018-02-06 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
WO2016033440A1 (en) * 2014-08-29 2016-03-03 Chdi Foundation, Inc. Probes for imaging huntingtin protein
US10561440B2 (en) 2015-09-03 2020-02-18 Vesatek, Llc Systems and methods for manipulating medical devices
US10492805B2 (en) 2016-04-06 2019-12-03 Walk Vascular, Llc Systems and methods for thrombolysis and delivery of an agent
JP6831802B2 (ja) * 2018-01-12 2021-02-17 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. 放射性核種標識化合物及びこれを含有するイメージング剤
US11678905B2 (en) 2018-07-19 2023-06-20 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU759945B2 (en) 1998-08-20 2003-05-01 Regents Of The University Of California, The Methods for labeling beta-amyloid plaques and neurofibrillary tangles
ES2395721T3 (es) 2000-08-24 2013-02-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Derivados de tioflavina y su uso en diagnosis y terapia de la enfermedad de alzheimer
EP1381604B1 (en) 2001-04-23 2006-12-27 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
WO2003018070A1 (en) 2001-08-27 2003-03-06 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1956013B1 (en) * 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
BRPI0711818A2 (pt) 2006-05-19 2011-12-13 Nihon Medi-Physics Co., Ltd. novo composto com afinidade pela amilóide
KR20100091965A (ko) * 2007-10-24 2010-08-19 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
CA2704027A1 (en) * 2007-10-26 2009-04-30 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
AU2008319985A1 (en) 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
CN101909659A (zh) 2007-10-30 2010-12-08 日本医事物理股份有限公司 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法
KR20100094478A (ko) 2007-10-30 2010-08-26 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
WO2010128595A1 (ja) 2009-05-07 2010-11-11 富士フイルムRiファーマ株式会社 放射性ヨウ素標識イミダゾピリジン誘導体の製造法

Also Published As

Publication number Publication date
TW201247226A (en) 2012-12-01
EP2716641A4 (en) 2014-12-10
CN103534253B (zh) 2016-02-24
CN103534253A (zh) 2014-01-22
EP2716641A1 (en) 2014-04-09
JPWO2012161116A1 (ja) 2014-07-31
AU2012259929B2 (en) 2016-08-04
KR20140040722A (ko) 2014-04-03
US9149546B2 (en) 2015-10-06
CA2836872A1 (en) 2012-11-29
AU2012259929A1 (en) 2014-01-16
EP2716641B1 (en) 2017-04-05
US20140228569A1 (en) 2014-08-14
ES2628221T3 (es) 2017-08-02
TWI528977B (zh) 2016-04-11
JP5272110B2 (ja) 2013-08-28
WO2012161116A1 (ja) 2012-11-29

Similar Documents

Publication Publication Date Title
IL286152A (en) Modified imidazopyridinyl-aminopyridine compounds
HK1252389A1 (zh) 喹諾酮化合物
ZA201401553B (en) Cyclopropaneamine compound
IL233154A0 (en) compounds
HK1193815A1 (zh) 對澱粉狀蛋白具有親和性的化合物
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
GB201106817D0 (en) New compound
ZA201306857B (en) Mesogen-containing compounds
GB201122139D0 (en) Compounds
GB201107197D0 (en) Compounds
EP2708540A4 (en) PYRIMIDO-DIAZEPINONE COMPOUND
HK1191326A1 (zh) 氮雜螺環癸酮化合物
EP2725027A4 (en) NEW COMPOUNDS WITH AMYLOIDAFFINITY
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
EP2729467A4 (en) KRYPTATVERBINDUNGEN
GB201118613D0 (en) Compounds
GB201104669D0 (en) Compound
GB201121538D0 (en) Compound
GB201118102D0 (en) Compound
GB201120805D0 (en) Compounds
GB201119745D0 (en) Compounds
GB201119703D0 (en) Compounds
GB201115827D0 (en) Compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200517